{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:15:53Z","timestamp":1788966953569,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["P910679"],"award-info":[{"award-number":["P910679"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-024-00664-x","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T04:35:16Z","timestamp":1731299716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of CREB and MAPK signaling pathways in ATLL patients"],"prefix":"10.1186","volume":"21","author":[{"given":"Mohammad Mehdi","family":"Akbarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Farjami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"664_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.941647","volume":"9","author":"RS Barr","year":"2022","unstructured":"Barr RS, Drysdale SB, Boullier M, Lyall H, Cook L, Collins GP, et al. A review of the prevention of mother-to-child transmission of human T-cell lymphotrophic virus type 1 (HTLV-1) with a proposed management algorithm. Front Med (Lausanne). 2022;9: 941647.","journal-title":"Front Med (Lausanne)"},{"key":"664_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/v13091753","volume":"13","author":"A Stufano","year":"2021","unstructured":"Stufano A, Jahantigh HR, Cagnazzo F, Centrone F, Loconsole D, Chironna M, et al. Work-related human t-lymphotropic virus 1 and 2 (HTLV-1\/2) infection: a systematic review. Viruses. 2021;13:9.","journal-title":"Viruses."},{"key":"664_CR3","doi-asserted-by":"publisher","first-page":"105622","DOI":"10.1016\/j.micpath.2022.105622","volume":"169","author":"S Ramezani","year":"2022","unstructured":"Ramezani S, Rezaee SA, Farjami Z, Ebrahimi N, Abdullabass HK, Ibrahim Jebur MI, et al. HTLV, a multi organ oncovirus. Microb Pathog. 2022;169:105622.","journal-title":"Microb Pathog"},{"key":"664_CR4","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.ensci.2023.100453","volume":"31","author":"K Tamaki","year":"2023","unstructured":"Tamaki K, Mishima T, Tateishi Y, Mera H, Ogura H, Tsugawa J, et al. HTLV-1-associated demyelinating neuropathy: a case report and review of the literature. NeurologicalSci. 2023;31:100453.","journal-title":"NeurologicalSci."},{"issue":"5","key":"664_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/DAD.0000000000002044","volume":"44","author":"BL Rosa","year":"2022","unstructured":"Rosa BL, Silva TS, Dias MA, Araujo I, Bittencourt AL. Progression of infective dermatitis associated with HTLV-1 to adult T-cell leukemia\/lymphoma-case report and literature review. Am J Dermatopathol. 2022;44(5):368\u201371.","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"664_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5045\/br.2017.52.2.106","volume":"52","author":"MM Akbarin","year":"2017","unstructured":"Akbarin MM, Shirdel A, Bari A, Mohaddes ST, Rafatpanah H, Karimani EG, et al. Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLLATLLL patients. Blood Res. 2017;52(2):106\u201311.","journal-title":"Blood Res"},{"issue":"4","key":"664_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00430-017-0506-1","volume":"206","author":"S Ramezani","year":"2017","unstructured":"Ramezani S, Shirdel A, Rafatpanah H, Akbarin MM, Tarokhian H, Rahimi H, et al. Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia\/lymphoma. Med Microbiol Immunol. 2017;206(4):327\u201335.","journal-title":"Med Microbiol Immunol"},{"issue":"1","key":"664_CR8","first-page":"88","volume":"6","author":"R Torshizi","year":"2017","unstructured":"Torshizi R, Ghayour Karimani E, Etminani K, Akbarin MM, Jamialahmadi K, Shirdel A, et al. Altered expression of cell cycle regulators in adult T-cell leukemia\/ lymphoma patients. Rep Biochem Mol Biol. 2017;6(1):88\u201394.","journal-title":"Rep Biochem Mol Biol"},{"issue":"4","key":"664_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00705-016-3213-0","volume":"162","author":"M Jafarian","year":"2017","unstructured":"Jafarian M, Mozhgani SH, Patrad E, Vaziri H, Rezaee SA, Akbarin MM, et al. Evaluation of INOS, ICAM-1, and VCAM-1 gene expression: a study of adult T cell leukemia malignancy associated with HTLV-1. Arch Virol. 2017;162(4):1009\u201315.","journal-title":"Arch Virol"},{"issue":"5","key":"664_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1517\/13543776.2014.894977","volume":"24","author":"S Buhler","year":"2014","unstructured":"Buhler S, Laufer SA. p38 MAPK inhibitors: a patent review (2012\u20132013). Expert Opin Ther Pat. 2014;24(5):535\u201354.","journal-title":"Expert Opin Ther Pat"},{"key":"664_CR11","doi-asserted-by":"crossref","unstructured":"Wydra VR, Ditzinger RB, Seidler NJ, Hacker FW, Laufer SA. A patent review of MAPK inhibitors (2018 - present). Expert Opin Ther Pat. 2023.","DOI":"10.1080\/13543776.2023.2242584"},{"issue":"1","key":"664_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00403-009-0994-y","volume":"302","author":"V Muthusamy","year":"2010","unstructured":"Muthusamy V, Piva TJ. The UV response of the skin: a review of the MAPK, NFkappaB and TNFalpha signal transduction pathways. Arch Dermatol Res. 2010;302(1):5\u201317.","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"664_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1439-0531.2003.00438.x","volume":"38","author":"AT Peter","year":"2003","unstructured":"Peter AT, Dhanasekaran N. Apoptosis of granulosa cells: a review on the role of MAPK-signalling modules. Reprod Domest Anim. 2003;38(3):209\u201313.","journal-title":"Reprod Domest Anim"},{"issue":"2","key":"664_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5114\/fn.2020.96734","volume":"58","author":"R Gruszka","year":"2020","unstructured":"Gruszka R, Zakrzewski K, Liberski PP, Zakrzewska M. microRNA interaction with MAPK and AKT pathways in paediatric brain tumours - preliminary results and review of the literature. Folia Neuropathol. 2020;58(2):123\u201332.","journal-title":"Folia Neuropathol"},{"key":"664_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ygyno.2023.01.038","volume":"171","author":"CSE Hendrikse","year":"2023","unstructured":"Hendrikse CSE, Theelen PMM, van der Ploeg P, Westgeest HM, Boere IA, Thijs AMJ, et al. The potential of RAS\/RAF\/MEK\/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis. Gynecol Oncol. 2023;171:83\u201394.","journal-title":"Gynecol Oncol"},{"key":"664_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/cancers11101618","volume":"11","author":"C Braicu","year":"2019","unstructured":"Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, et al. A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers (Basel). 2019;11:10.","journal-title":"Cancers (Basel)."},{"key":"664_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110853","volume":"132","author":"A Safa","year":"2020","unstructured":"Safa A, Abak A, Shoorei H, Taheri M, Ghafouri-Fard S. MicroRNAs as regulators of ERK\/MAPK pathway: a comprehensive review. Biomed Pharmacother. 2020;132: 110853.","journal-title":"Biomed Pharmacother"},{"key":"664_CR18","doi-asserted-by":"crossref","unstructured":"Vecchi C, Montosi G, Garuti C, Canali S, Sabelli M, Bergamini E, et al. CREB-H is a stress-regulator of hepcidin gene expression during early postnatal development. J Mol Med (Berl). 2023.","DOI":"10.1007\/s00109-023-02344-1"},{"key":"664_CR19","doi-asserted-by":"crossref","unstructured":"Wang Z, Lu Z, Chen Y, Wang C, Gong P, Jiang R, et al. Targeting the AKT-P53\/CREB pathway with epicatechin for improved prognosis of traumatic brain injury. CNS Neurosci Ther. 2023.","DOI":"10.1111\/cns.14364"},{"key":"664_CR20","doi-asserted-by":"publisher","first-page":"112030","DOI":"10.1016\/j.mce.2023.112030","volume":"1","author":"M Rodriguez Esquivel","year":"2023","unstructured":"Rodriguez Esquivel M, Hayes E, Lakomy O, Hassan M, Foretz M, Stocco C. Salt-inducible kinases regulate androgen synthesis in theca cells by enhancing CREB signaling. Mol Cell Endocrinol. 2023;1:112030.","journal-title":"Mol Cell Endocrinol."},{"key":"664_CR21","doi-asserted-by":"publisher","first-page":"112033","DOI":"10.1016\/j.mce.2023.112033","volume":"1","author":"S Yang","year":"2023","unstructured":"Yang S, Jia Y, Wu Z, Fu B, Zhou S, Pires LV, et al. Activation of G protein-coupled estrogen receptor stimulates placental human chorionic gonadotropin expression through PKA-CREB signaling. Mol Cell Endocrinol. 2023;1:112033.","journal-title":"Mol Cell Endocrinol."},{"issue":"1","key":"664_CR22","first-page":"1","volume":"9","author":"N Kandezi","year":"2020","unstructured":"Kandezi N, Mohammadi M, Ghaffari M, Gholami M, Motaghinejad M, Safari S. Novel insight to neuroprotective potential of curcumin: a mechanistic review of possible involvement of mitochondrial biogenesis and PI3\/Akt\/ GSK3 or PI3\/Akt\/CREB\/BDNF signaling pathways. Int J Mol Cell Med. 2020;9(1):1\u201332.","journal-title":"Int J Mol Cell Med"},{"issue":"1","key":"664_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s13046-021-01967-x","volume":"40","author":"V Mlakar","year":"2021","unstructured":"Mlakar V, Morel E, Mlakar SJ, Ansari M, Gumy-Pause F. A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma. J Exp Clin Cancer Res. 2021;40(1):189.","journal-title":"J Exp Clin Cancer Res"},{"key":"664_CR24","first-page":"11","volume":"22","author":"SR D'Mello","year":"2021","unstructured":"D\u2019Mello SR. When good kinases go rogue: GSK3, p38 MAPK and CDKs as therapeutic targets for alzheimer\u2019s and huntington\u2019s disease. Int J Mol Sci. 2021;22:11.","journal-title":"Int J Mol Sci."},{"issue":"4","key":"664_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1051\/medsci\/2022039","volume":"38","author":"C Martella","year":"2022","unstructured":"Martella C, Waast L, Pique C. Tax, the puppet master of HTLV-1 transcription. Med Sci (Paris). 2022;38(4):359\u201365.","journal-title":"Med Sci (Paris)"},{"issue":"9","key":"664_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009919","volume":"17","author":"C Vandermeulen","year":"2021","unstructured":"Vandermeulen C, O\u2019Grady T, Wayet J, Galvan B, Maseko S, Cherkaoui M, et al. The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape. PLoS Pathog. 2021;17(9): e1009919.","journal-title":"PLoS Pathog"},{"key":"664_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/jci.insight.128713","volume":"4","author":"J Xiang","year":"2019","unstructured":"Xiang J, Rauch DA, Huey DD, Panfil AR, Cheng X, Esser AK, et al. HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia. JCI Insight. 2019;4:19.","journal-title":"JCI Insight."},{"key":"664_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2023.04.004","volume":"1","author":"J Shao","year":"2023","unstructured":"Shao J, Yu W, Wei W, Wang S, Zheng Z, Li L, et al. MAPK-ERK-CREB signaling pathway upregulates Nav16 in oxaliplatin-induced neuropathic pain in the rat. Toxicol Lett. 2023;1:1.","journal-title":"Toxicol Lett."},{"key":"664_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1742-4690-3-43","volume":"3","author":"C de la Fuente","year":"2006","unstructured":"de la Fuente C, Gupta MV, Klase Z, Strouss K, Cahan P, McCaffery T, et al. Involvement of HTLV-I Tax and CREB in aneuploidy: a bioinformatics approach. Retrovirology. 2006;3:43.","journal-title":"Retrovirology"},{"issue":"2","key":"664_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/jb\/117.2.303","volume":"117","author":"Y Matsuzaki","year":"1995","unstructured":"Matsuzaki Y, Fujisawa J, Yoshida M. Identification of transcriptional activation domain of TREB5, a CREB\/ATF family protein that binds to HTLV-1 enhancer. J Biochem. 1995;117(2):303\u20138.","journal-title":"J Biochem"},{"issue":"43","key":"664_CR31","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1021\/bi0353023","volume":"42","author":"AC Vendel","year":"2003","unstructured":"Vendel AC, McBryant SJ, Lumb KJ. KIX-mediated assembly of the CBP-CREB-HTLV-1 tax coactivator-activator complex. Biochemistry. 2003;42(43):12481\u20137.","journal-title":"Biochemistry"},{"key":"664_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1742-4690-6-73","volume":"6","author":"S Jiang","year":"2009","unstructured":"Jiang S, Inada T, Tanaka M, Furuta RA, Shingu K, Fujisawa J. Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1. Retrovirology. 2009;6:73.","journal-title":"Retrovirology"},{"issue":"14","key":"664_CR33","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1038\/onc.2009.498","volume":"29","author":"YM Kim","year":"2010","unstructured":"Kim YM, Geiger TR, Egan DI, Sharma N, Nyborg JK. The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription. Oncogene. 2010;29(14):2142\u201352.","journal-title":"Oncogene"},{"issue":"4","key":"664_CR34","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1128\/JVI.00480-06","volume":"81","author":"I Lemasson","year":"2007","unstructured":"Lemasson I, Lewis MR, Polakowski N, Hivin P, Cavanagh MH, Thebault S, et al. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol. 2007;81(4):1543\u201353.","journal-title":"J Virol"},{"issue":"10","key":"664_CR35","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1007\/s11033-013-2706-0","volume":"40","author":"Y Ma","year":"2013","unstructured":"Ma Y, Zheng S, Wang Y, Zang W, Li M, Wang N, et al. The HTLV-1 HBZ protein inhibits cyclin D1 expression through interacting with the cellular transcription factor CREB. Mol Biol Rep. 2013;40(10):5967\u201375.","journal-title":"Mol Biol Rep"},{"issue":"1\u20132","key":"664_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jneuroim.2004.10.007","volume":"159","author":"N Fukushima","year":"2005","unstructured":"Fukushima N, Nishiura Y, Nakamura T, Yamada Y, Kohno S, Eguchi K. Involvement of p38 MAPK signaling pathway in IFN-gamma and HTLV-I expression in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Neuroimmunol. 2005;159(1\u20132):196\u2013202.","journal-title":"J Neuroimmunol"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-024-00664-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-024-00664-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-024-00664-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T17:01:47Z","timestamp":1731344507000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-024-00664-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1186\/s12981-024-00664-x","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the samples and methods mentioned above were approved by the Research Ethics Committee of Mashhad University of Medical Sciences in Iran (ethical code: 910679). All patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}